Skip to main content
Clinical Trials/CTRI/2022/01/039863
CTRI/2022/01/039863CompletedPhase 2

Preclinical and clinical evaluation of the effect on oral administration of KARUNJEERAKA MATHIRAI along with external application of NUNAA TAILAM in the management of VENPADAI in children

Dr S Surendar0 sites0 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 2
Status
Completed
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • 1.Hypo pigemented patches surrounded by hyper pigemneted border present in any part of the body

Exclusion Criteria

  • 1.Children above 12 years
  • 2.Children below 3 years
  • 3.Albinism
  • 4.Pie-baldism
  • 5.Hypo pigmented patches start firstly in lips and genital area
  • 6.Depigemented patches after burns
  • 7.Juvenile diabetes with vitiligo

Investigators

Sponsor
Dr S Surendar

Similar Trials